Loading...
Camurus AB (publ)
0RD1.L•LSE
Healthcare
Medical - Pharmaceuticals
£603.79
£-7.98(-1.30%)
Camurus AB (publ) (0RD1.L) Financial Performance & Statements
Review Camurus AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
8.78%
↑ 8.78%
Operating Income Growth
-11.87%
↓ 11.87%
Net Income Growth
-0.71%
↓ 0.71%
Operating Cash Flow Growth
-36.07%
↓ 36.07%
Operating Margin
25.26%
↑ 25.26%
Gross Margin
92.87%
↑ 92.87%
Net Profit Margin
22.94%
↑ 22.94%
ROE
14.31%
↑ 14.31%
ROIC
14.22%
↑ 14.22%
Camurus AB (publ) (0RD1.L) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Camurus AB (publ) stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $553.13M | $479.60M | $444.87M | $390.00M |
| Cost of Revenue | $33.32M | $33.51M | $35.55M | $30.87M |
| Gross Profit | $519.81M | $446.08M | $409.32M | $359.13M |
| Gross Profit Ratio | $0.94 | $0.93 | $0.92 | $0.92 |
| R&D Expenses | $167.29M | $162.76M | $169.80M | $180.03M |
| SG&A Expenses | $181.44M | $138.52M | $154.67M | $109.10M |
| Operating Expenses | $353.74M | $304.26M | $324.47M | $311.00M |
| Total Costs & Expenses | $387.06M | $337.77M | $360.02M | $311.00M |
| Interest Income | $20.46M | $23.72M | $21.78M | $18.48M |
| Interest Expense | $284000.00 | $235000.00 | $277000.00 | $288000.00 |
| Depreciation & Amortization | $3.51M | $3.69M | $3.75M | $3.68M |
| EBITDA | $190.04M | $169.24M | $88.59M | $100.83M |
| EBITDA Ratio | $0.34 | $0.35 | $0.20 | $0.26 |
| Operating Income | $166.07M | $141.83M | $84.85M | $79.00M |
| Operating Income Ratio | $0.30 | $0.30 | $0.19 | $0.20 |
| Other Income/Expenses (Net) | $20.18M | $23.48M | $19.26M | $18.20M |
| Income Before Tax | $186.24M | $165.31M | $104.11M | $97.00M |
| Income Before Tax Ratio | $0.34 | $0.34 | $0.23 | $0.25 |
| Income Tax Expense | $39.26M | $35.96M | $29.91M | $19.00M |
| Net Income | $146.98M | $129.35M | $74.20M | $77.86M |
| Net Income Ratio | $0.27 | $0.27 | $0.17 | $0.20 |
| EPS | $2.50 | $2.21 | $1.28 | $1.36 |
| Diluted EPS | $2.45 | $2.16 | $1.25 | $1.32 |
| Weighted Avg Shares Outstanding | $58.82M | $58.65M | $57.78M | $57.25M |
| Weighted Avg Shares Outstanding (Diluted) | $59.93M | $59.92M | $59.53M | $59.10M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan